Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

PARADIGM BIOPHARMACEUTICALS LTD. APPOINTS MARCO POLIZZI as CHIEF EXECUTIVE OFFICER

Polizzi Possesses More Than 30 Years of Experience in the Pharmaceutical Industry. NEW YORK, June 27, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a clinical-stage biopharmaceutical company focused on repurposing existing molecules for new indications with unmet clinical needs, …

EODHD | 27 June 2022

Is Genuit Group plc (LON:GEN) Potentially Undervalued?

Genuit Group plc (LON:GEN), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the LSE over the last few months, increasing to UK£5.38 at one point, and dropping to the lows of UK£3.80. …

EODHD | 27 June 2022

Those who invested in Murray Cod Australia (ASX:MCA) five years ago are up 163%

Some Murray Cod Australia Limited (ASX:MCA) shareholders are probably rather concerned to see the share price fall 42% over the last three months. But in stark contrast, the returns over the last half decade have impressed. It's fair to say most would be happy …

EODHD | 27 June 2022

Declining Stock and Decent Financials: Is The Market Wrong About Ingenia Communities Group (ASX:INA)?

Ingenia Communities Group (ASX:INA) has had a rough three months with its share price down 18%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus …

EODHD | 27 June 2022

Ricegrowers (ASX:SGLLV) Has Announced That Its Dividend Will Be Reduced To AU$0.30

Ricegrowers Limited (ASX:SGLLV) is reducing its dividend to AU$0.30 on the 29th of July. This means the annual payment is 5.3% of the current stock price, which is above the average for the industry. Check out our latest analysis for Ricegrowers Ricegrowers' Dividend Is …

EODHD | 26 June 2022

An Intrinsic Calculation For Johns Lyng Group Limited (ASX:JLG) Suggests It's 39% Undervalued

Today we will run through one way of estimating the intrinsic value of Johns Lyng Group Limited (ASX:JLG) by projecting its future cash flows and then discounting them to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. There's …

EODHD | 26 June 2022

Data#3's (ASX:DTL) 28% CAGR outpaced the company's earnings growth over the same five-year period

While Data#3 Limited (ASX:DTL) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 15% in the last quarter. But that scarcely detracts from the really solid long term returns generated by the company over five …

EODHD | 25 June 2022

Analysts Expect Breakeven For Kalium Lakes Limited (ASX:KLL) Before Long

With the business potentially at an important milestone, we thought we'd take a closer look at Kalium Lakes Limited's (ASX:KLL) future prospects. Kalium Lakes Limited operates as an exploration and development company in Australia. The AU$77m market-cap company posted a loss in its most …

EODHD | 24 June 2022

Return Trends At Nuix (ASX:NXL) Aren't Appealing

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from …

EODHD | 24 June 2022

argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe

argenx SE Positive opinion based on Phase 3 ADAPT trial showing efgartigimod provided clinically meaningful improvements in strength and quality of life measures European Commission decision on marketing authorization application (MAA) expected in approximately 60 days If approved, efgartigimod will be the first neonatal …

EODHD | 24 June 2022

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions